Sutro Biopharma (STRO) EBIT Margin (2017 - 2026)
Sutro Biopharma's EBIT Margin was -303.77% in Q2 2026, down 298.52 percentage points from -5.25% a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) EBIT Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sutro Biopharma's EBIT Margin was -126.14% through Jun 30, 2026, up 70.11 percentage points year-over-year; for FY2025, it came in at -154.53%, up 229.81 percentage points from FY2024.
- EBIT Margin shows a five-year change of +11.80 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -384.34% in FY2024 (-326.26 pp), -58.07% in FY2023 (+132.19 pp), -190.26% in FY2022 (-31.04 pp) and -159.22% in FY2021 (+7.11 pp).
- Quarterly EBIT Margin has moved between -797.17% (Q3 2024) and 37.95% (Q4 2023) over five years.
- Compared with a year earlier, EBIT Margin was higher in four of the last seven quarters, with an average year-over-year change of -96.80 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2023 (a gain of 608.17 percentage points); the worst was Q3 2024 (a drop of 537.10 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - | -303.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -303.77% |
| Dec 31, 2025 | -326.68% |
| Sep 30, 2025 | -499.94% |
| Jun 30, 2025 | -5.25% |
| Mar 31, 2025 | -393.78% |
| Dec 31, 2024 | -440.66% |
| Sep 30, 2024 | -797.17% |
| Jun 30, 2024 | -189.39% |
| Mar 31, 2024 | -435.05% |
| Dec 31, 2023 | 37.95% |
| Sep 30, 2023 | -260.07% |
| Jun 30, 2023 | -443.52% |
| Mar 31, 2023 | -333.26% |
| Dec 31, 2022 | -570.23% |
| Sep 30, 2022 | -84.34% |
| Jun 30, 2022 | -68.97% |
| Mar 31, 2022 | -663.59% |
| Dec 31, 2021 | -328.85% |
| Sep 30, 2021 | -407.12% |
| Jun 30, 2021 | -34.96% |
API Access
Sutro Biopharma EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();